These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5985259)

  • 1. Pharmacokinetic and metabolic studies with labeled rifamycin antibiotics.
    Keberle H; Meyer-Brunot H; Schmid K
    Antimicrob Agents Chemother (Bethesda); 1966; 6():365-70. PubMed ID: 5985259
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.
    Furesz S; Scotti R; Pallanza R; Mapelli E
    Arzneimittelforschung; 1967 May; 17(5):534-7. PubMed ID: 5631581
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of a chloramphenicol-rifampicin combination in rats].
    Cantelli Forti G; Fracasso ME
    Boll Soc Ital Biol Sper; 1971 Oct; 47(19):575-7. PubMed ID: 5140771
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental hepatic repercussions of antibiotic therapy].
    Billing BH; Goulis G; Acocella G
    Rev Int Hepatol; 1966; 16(2):389-91. PubMed ID: 5947855
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.
    Fattinger K; Cattori V; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2000 Jul; 32(1):82-6. PubMed ID: 10869292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
    Emary WB; Toren PC; Mathews B; Huh K
    Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic clearance and urinary excretion of rifamycin in patients with or without liver diseases].
    Rodriguez Garay EA; Laudano OM; Spetale Mdel R
    Farmaco Prat; 1970 Jul; 25(7):423-7. PubMed ID: 5469691
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in oxygen consumption of the liver in rats treated with rifamycin].
    Furnò O; Salmeri G; Gulisano G
    Boll Soc Ital Biol Sper; 1966 May; 42(10):569-71. PubMed ID: 5916061
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution, excretion and toxicity of rifazine, a new semisynthetic rifamycin.
    Schiatti P; Dezulian VM; Serralunga MG; Maffii G
    Chemotherapy; 1967; 12(4):247-60. PubMed ID: 6065358
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental research on the organotropism at the maternal and fetal level of rifamycin SV].
    Bertè E; Moncalvo F
    G Ital Tuberc Mal Torace; 1965; 19(6):248-51. PubMed ID: 5893317
    [No Abstract]   [Full Text] [Related]  

  • 11. Causes for rifampicin toxicity--experimental study.
    Zítková L; Stastná J; Dobrovský K; Tousek J
    Czech Med; 1982; 5(4):210-7. PubMed ID: 6818008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interactions of chloramphenicol and rifampicin in relation to their pharmacokinetic properties].
    Cantelli Forti G; Fracasso ME
    Clin Ter; 1972 Apr; 61(1):59-66. PubMed ID: 5039602
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution and excretion of rifamide in rats and dogs.
    Maffii G; Schiatti P
    Toxicol Appl Pharmacol; 1966 Jan; 8(1):138-51. PubMed ID: 5921889
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue distribution and biliary excretion of prostacyclin metabolites in the rat.
    Taylor BM; Sun FF
    J Pharmacol Exp Ther; 1980 Jul; 214(1):24-30. PubMed ID: 6993658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicompartimental model for the study of drugs with high biliary excretion, used in the study of the kinetics of rifampicin in man].
    Acocella G; Pagani V; Nicolis FB
    Boll Chim Farm; 1972 Feb; 111(2):108-15. PubMed ID: 5045532
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the distribution between the blood and cerebrospinal fluid of rifamycin AMP].
    Curci G; Della Cava F; Vitale L
    Minerva Med; 1969 Jun; 60(48):2399-402. PubMed ID: 5794578
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New derivatives of rifamycin antibiotics.
    Bickel H; Knüsel F; Kump W; Neipp L
    Antimicrob Agents Chemother (Bethesda); 1966; 6():352-8. PubMed ID: 5985257
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of major metabolic pathways for chlordecone (kepone) in humans.
    Fariss MW; Blanke RV; Saady JJ; Guzelian PS
    Drug Metab Dispos; 1980; 8(6):434-8. PubMed ID: 6161768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.